Acadia Healthcare (NASDAQ:ACHC – Get Free Report) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research note issued on Monday, Zacks reports.
ACHC has been the subject of several other research reports. Leerink Partners lifted their price target on Acadia Healthcare from $30.00 to $33.00 and gave the company a “market perform” rating in a research note on Wednesday, September 23rd. TD Cowen increased their price target on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Royal Bank Of Canada raised their price objective on Acadia Healthcare from $31.00 to $41.00 and gave the company an “outperform” rating in a report on Friday. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Finally, Raymond James Financial initiated coverage on Acadia Healthcare in a research report on Wednesday, November 4th. They issued a “moderate buy” rating for the company. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $32.54.
Get Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Stock Up 0.1%
ACHC stock opened at $38.64 on Monday. Acadia Healthcare has a one year low of $11.43 and a one year high of $39.70. The company has a debt-to-equity ratio of 1.15, a quick ratio of 1.60 and a current ratio of 1.60. The firm’s fifty day moving average is $29.83 and its 200 day moving average is $26.38. The firm has a market cap of $3.59 billion, a PE ratio of -3.10, a P/E/G ratio of 11.08 and a beta of 0.64.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.46 by $0.14. Acadia Healthcare had a negative net margin of 33.07% and a positive return on equity of 6.53%. The business had revenue of $895.31 million during the quarter, compared to the consensus estimate of $877.76 million. During the same quarter in the prior year, the firm posted $0.72 earnings per share. The company’s revenue was up 5.1% compared to the same quarter last year. On average, research analysts forecast that Acadia Healthcare will post 1.74 EPS for the current year.
Institutional Investors Weigh In On Acadia Healthcare
Several institutional investors and hedge funds have recently added to or reduced their stakes in ACHC. Allworth Financial LP acquired a new stake in shares of Acadia Healthcare in the second quarter valued at about $45,000. Global Retirement Partners LLC acquired a new position in Acadia Healthcare during the second quarter worth about $68,000. Integrated Wealth Concepts LLC acquired a new position in Acadia Healthcare during the second quarter worth about $79,000. Hantz Financial Services Inc. grew its stake in Acadia Healthcare by 34.8% during the 3rd quarter. Hantz Financial Services Inc. now owns 3,006 shares of the company’s stock valued at $83,000 after acquiring an additional 776 shares in the last quarter. Finally, Quantbot Technologies LP purchased a new stake in Acadia Healthcare during the 2nd quarter valued at about $88,000.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc. is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care. Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program. Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.
See Also
- Five stocks we like better than Acadia Healthcare
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
